Verified· 3 sources

Limula SA

Summary

About the company

The core activity of Limula SA is the development and provision of a revolutionary platform for the manufacture of cell and gene therapies (Cell & Gene Therapy, CGT). The company focuses on enabling the transition from open and manual methods to closed and automated processes in CGT manufacturing.

AI-generated

Offering

Products & services

Industry:Medical Technology Industry

✓ Offered5

Platform for the manufacture of cell and gene therapies

Platform for end-to-end manufacturing of highly personalized cell therapies in a single container, with automated, closed and scalable processes for research and clinical production.

LimGROW

LimGROW is a research and process development platform for incubation steps, for developing, optimizing and validating processes before automation.

LimONE

LimONE is an automated platform for clinical applications and commercial production, with closed workflows, precise process control and end-to-end automation.

Early access and partnerships

Early access to the technology for selected partners with a suitable use case, as well as partnerships across the Cell & Gene Therapy value chain.

Investor engagement

Engaging investors to support the company’s vision and to finance further development in the field of Cell and Gene Therapy.

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

Limula SA

About the company

Products & services

Looking for direct email addresses and phone numbers?

Limula SA

About the company

Products & services

Looking for direct email addresses and phone numbers?

Media

No knowledge articles yet

Limula SA in comparison

Industry comparisons are coming soon

Similar companies